Comparison between Parabolic Drugs IPO and SJVN IPO.
Parabolic Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SJVN IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the SJVN IPO is up to ₹1,062.74 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of SJVN IPO is ₹26.00 per share.
| Parabolic Drugs IPO | SJVN IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | ₹23.00 per share |
| Issue Price (Upper) | ₹85.00 per share | ₹26.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹26.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹1.30 per share |
| Discount (Employee) | ₹0.00 per share | ₹1.30 per share |
| Market Lot Size | 80 shares | 250 shares |
| Fresh Issue Size | 2,46,40,965 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹184.81 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 20,25,702 shares | 41,50,00,000 shares |
| OFS Issue Size (Amount) | up to ₹15.19 Cr | up to ₹1,062.74 Cr |
| Issue Size Total | 2,66,66,667 shares | 41,50,00,000 shares |
| Issue Size Total (Amount) | up to ₹200.00 Cr | up to ₹1,062.74 Cr |
Parabolic Drugs IPO opens on Jun 14, 2010, while SJVN IPO opens on Apr 29, 2010. The closing date of Parabolic Drugs IPO and SJVN IPO is Jun 17, 2010, and May 03, 2010, respectively.
| Parabolic Drugs IPO | SJVN IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 14, 2010 | Apr 29, 2010 |
| Issue Close | Jun 17, 2010 | May 03, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jul 01, 2010 | May 20, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Parabolic Drugs IPO P/E ratio is , as compared to SJVN IPO P/E ratio of .
| Parabolic Drugs IPO | SJVN IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.21 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 38.04 | 89.97 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹464.19 Cr. | ₹10682.92 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 19.96 | 12.5 |
In the Parabolic Drugs IPO Retail Individual Investors (RII) are offered 91,58,334 shares while in SJVN IPO retail investors are offered 91,58,334 shares. Qualified Institutional Buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 24,69,90,000 shares in SJVN IPO.
| Parabolic Drugs IPO | SJVN IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 1,30,83,333 shares | 24,69,90,000 shares |
| NII | 39,25,000 shares | 4,11,65,000 shares |
| RII | 91,58,334 shares | 12,34,95,000 shares |
| Employee | 5,00,000 shares | 33,50,000 shares |
| Others | ||
| Total | 2,66,66,667 shares | 41,50,00,000 shares |
Parabolic Drugs IPO subscribed 1.04x in total, whereas SJVN IPO subscribed 6.64x.
| Parabolic Drugs IPO | SJVN IPO | |
|---|---|---|
| QIB (times) | 1.48x | 9.03x |
| NII (times) | 1.20x | 3.39x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.40x | 3.12x |
| Employee (times) | 0.11x | 0.25x |
| Other (times) | ||
| Total (times) | 1.04x | 6.64x |
